Covidien Ltd Completes Previously Announced Transactions

5/20/2008 9:28:18 AM

HAMILTON, Bermuda--(BUSINESS WIRE)--Covidien Ltd. (NYSE: COV, BSX: COV) today announced that one of its subsidiaries has acquired 100% ownership of Tissue Science Laboratories, a medical device company dedicated to the research, development and commercialization of tissue implant products for surgical and wound care therapies. Covidien launched a public tender offer in the United Kingdom for all of Tissue Science Laboratories outstanding shares held by UK residents on March 12, 2008.

Read at BioSpace.com

Read Article at

Related Companies

News Categories

• BioSpace.com

• Tissue Science Laboratories PLC

• Covidien

• Medical Devices

• Medical Dev. & Diag. - Mergers and Acquisitions